Science News
from research organizations

Bacteriolytic therapy may be a promising treatment strategy for advanced pancreatic cancer patients

Date:
August 2, 2010
Source:
World Journal of Gastroenterology
Summary:
Pancreatic carcinoma is only rarely curable. A German research group investigated an alternative treatment using spores of the bacterium Clostridium novyi in an animal model. Tumors of a defined medium size were successfully treated. Small tumors remained unaffected and the treatment was toxic for animals with very large tumors. Successful treatment was due to the induction of an immune response predominantly the innate arm of the immune system.
Share:
       
FULL STORY

The aim of cancer immunotherapy is the stimulation of immune mechanisms to recognize malignant cells and may be a useful complementary therapy to conventional anticancer therapy. Immunotherapy was initiated over 100 years ago when New York surgeon William B. Coley inoculated a bacterial vaccine consisting of Streptococcus pyogenes and Serratia marcescens. Several patients experienced a beneficial effect on malignancy and were finally cured of their tumours by the development of a potent immune response.

A research article to be published on July 28,2010 in the World Journal of Gastroenterology worked on this old idea. The research team led by Dr. Michael Linnebacher from the University of Rostock treated pancreatic carcinoma with Clostridium novyi-spores. In their experimental model they analyzed animals with tumours of different sizes. Treatment success depended on tumour size. Small tumours were completely unaffected whereas the treatment was toxic in cases of very large tumours. Most interestingly, tumours of a defined medium size completely disappeared and animals remained free of tumour recurrence. The authors showed that immune mechanisms were responsible for this success.

The bacterial spores germinate and grow in the oxygen-free tumour centres where they damage surrounding tumour cells. This together with an infection-driven infiltration of tumours by cells of the innate immune system leads to significant damage to tumours.

These data indicate that the application of bacteria may be a promising treatment strategy for patients with advanced pancreatic cancer and warrants further investigation.


Story Source:

The above story is based on materials provided by World Journal of Gastroenterology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Maletzki C, Gock M, Klier U, Klar E, Linnebacher M. Bacteriolytic therapy of experimental pancreatic carcinoma. Chirurgisches Forum und DGAV Forum 2009, 2009; 3861 DOI: 10.1007/978-3-642-00625-8_24

Cite This Page:

World Journal of Gastroenterology. "Bacteriolytic therapy may be a promising treatment strategy for advanced pancreatic cancer patients." ScienceDaily. ScienceDaily, 2 August 2010. <www.sciencedaily.com/releases/2010/08/100802091209.htm>.
World Journal of Gastroenterology. (2010, August 2). Bacteriolytic therapy may be a promising treatment strategy for advanced pancreatic cancer patients. ScienceDaily. Retrieved May 25, 2015 from www.sciencedaily.com/releases/2010/08/100802091209.htm
World Journal of Gastroenterology. "Bacteriolytic therapy may be a promising treatment strategy for advanced pancreatic cancer patients." ScienceDaily. www.sciencedaily.com/releases/2010/08/100802091209.htm (accessed May 25, 2015).

Share This Page: